[[1] Costa P, Lobo JMS. Modelling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13:123-133.10.1016/S0928-0987(01)00095-1]Search in Google Scholar
[[2] Kohler AN, Murphree ES. A comparison of the Akaike and Schwarz criteria for selecting model order. Appl Statist. 1998;37:187-195.]Search in Google Scholar
[[3] Ludden TM, Beal SL, Sheiner LB. Comparison of the Akaike Information Criterion, the Schwarz criterion and the F test as guides to model selection. J. Pharmacokinetic Biopharm. 1994;22:431-445.10.1007/BF023538647791040]Search in Google Scholar
[[4] Martindale, The Complete Drug Reference. 37th ed. London, Pharmaceutical Press; 2011, 1367p.]Search in Google Scholar
[[5] Ramteke KH, Dighe PA, Kharat AR, Patil SV. Mathematical models of drug dissolution: a review. Sch. Acad. J. Pharm. 2014;3:388-396.]Search in Google Scholar
[[6] Sathe PM, Tsong Y, Shah VP. In-vitro dissolution profile comparison: statistics and analysis, model dependent approach. Pharm Res. 1996;13:1799-1803.10.1023/A:1016020822093]Search in Google Scholar
[[7] The United States Pharmacopeia. 36th ed. Rockwell: United States Pharmacopeial Convention, 2014.]Search in Google Scholar
[[8] van Vooren L, Krikilion G, Rosier J, de Spiegelee B. A novel bending point criterion for dissolution profile interpretation. Drug Dev Ind Pharm. 2001;27:885-892.10.1081/DDC-10010725411699842]Search in Google Scholar
[[9] Ward A, Clissold SP. Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 1987;34:50-97.10.2165/00003495-198734010-000033308412]Search in Google Scholar
